Volume 23 - Issue 12 - December 2015
Department
Research in Review
11/15/2016
Alexander K. Leung, MD, and Benjamin Barankin, MD
A 40-year-old East Indian man presented with a chronic, recurrent, erythematous rash limited to the inguinal and axillary areas for the past 3 years
A 40-year-old East Indian man presented with a chronic, recurrent, erythematous rash limited to the inguinal and axillary areas for the past 3 years
A 40-year-old East Indian...
11/15/2016
The Dermatologist
The Dermatopathologist
12/22/2015
A 23-year-old man presented with aclassic presentation of generalized eruptive histiocytosis.
A 23-year-old man presented with aclassic presentation of generalized eruptive histiocytosis.
A 23-year-old man presented with...
12/22/2015
The Dermatologist
04/06/2016
In this excerpt from the recently published book, Practical Psoriasis Management, the author discusses the use of apremilast for moderate-to-severe psoriasis.
In this excerpt from the recently published book, Practical Psoriasis Management, the author discusses the use of apremilast for moderate-to-severe psoriasis.
In this excerpt from the...
04/06/2016
The Dermatologist
Interactive Features
FDA Alerts
01/25/2016
FDA has approved nivolumab (Opdivo) in combination with ipilimumab (Yervoy) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma.
FDA has approved nivolumab (Opdivo) in combination with ipilimumab (Yervoy) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma.
FDA has approved nivolumab...
01/25/2016
The Dermatologist
FDA Alerts
01/16/2016
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
The FDA recently approved...
01/16/2016
The Dermatologist
News
News
01/22/2016
The aerosol foam formulation of fixed combination calcipotriene plus betamethasone dipropionate (Cal/BD, Enstilar) is efficacious in patients with psoriasis vulgaris according to new pooled data from 3 randomized controlled studies presented...
The aerosol foam formulation of fixed combination calcipotriene plus betamethasone dipropionate (Cal/BD, Enstilar) is efficacious in patients with psoriasis vulgaris according to new pooled data from 3 randomized controlled studies presented...
The aerosol foam formulation of...
01/22/2016
The Dermatologist
News
01/22/2016
FDA has approved Allergan’s supplemental new drug application to update the label for dalbavancin (Dalvance) for injection. The expanded label will include a single dose administered as a 30-minute intravenous (IV) infusion of dalbavancin for...
FDA has approved Allergan’s supplemental new drug application to update the label for dalbavancin (Dalvance) for injection. The expanded label will include a single dose administered as a 30-minute intravenous (IV) infusion of dalbavancin for...
FDA has approved Allergan’s...
01/22/2016
The Dermatologist
News
01/08/2016
A recent open label study,1 conducted between July and September 2012, examined microbial communities of patients with psoriasis vulgaris who were characterized prior and post a 3-week selenium-rich water balneotherapy treatment at the...
A recent open label study,1 conducted between July and September 2012, examined microbial communities of patients with psoriasis vulgaris who were characterized prior and post a 3-week selenium-rich water balneotherapy treatment at the...
A recent open label...
01/08/2016
The Dermatologist
News
01/06/2016
L’Oréal Group’s skincare brand, La Roche-Posay, revealed its My UV Patch, a novel stretchable skin sensor designed to monitor UV exposure and help consumers educate themselves about sun protection, at the Consumer Electronics Show today.
L’Oréal Group’s skincare brand, La Roche-Posay, revealed its My UV Patch, a novel stretchable skin sensor designed to monitor UV exposure and help consumers educate themselves about sun protection, at the Consumer Electronics Show today.
L’Oréal Group’s skincare brand,...
01/06/2016
The Dermatologist
Column
Therapeutic Review
12/22/2015
Researchers conducted a systematic literature review of 73 published studies to identify factors associated with treatment non-adherence across diseases in rheumatology, gastroenterology and dermatology.
Researchers conducted a systematic literature review of 73 published studies to identify factors associated with treatment non-adherence across diseases in rheumatology, gastroenterology and dermatology.
Researchers conducted a...
12/22/2015
The Dermatologist
